Human metapneumovirus, or hMPV, doesn’t get the same attention as influenza or COVID-19, but it’s worth understanding. It was first identified in 2001, though genetic studies suggest it has circulated for decades, and it’s a member of the Paramyxoviridae family, the same family that includes RSV.
Transmission is through respiratory droplets. That means coughing, sneezing, or close contact with an infected person is usually how it spreads, and anyone can get it, though young children, older adults, and people with weakened immune systems are most vulnerable to severe illness.
Where It Shows Up
hMPV is found worldwide. It circulates throughout the year but tends to spike in late winter and spring in temperate regions, and improved diagnostics over the last two decades have shown just how common it is. Clusters show up in schools, childcare centers, nursing homes, and hospitals. Often alongside influenza and RSV activity.
In the United States, the CDC tracks it as part of routine respiratory surveillance, and globally, WHO lists it as one of several viruses contributing to seasonal surges of respiratory illness.
Symptoms and Overlap
The symptoms of hMPV are familiar. Patients may have fever, cough, sore throat, congestion, fatigue, and sometimes wheezing, and in healthy people, illness usually resolves within one to two weeks. In infants, older adults, or immunocompromised patients, the disease can progress to bronchiolitis or pneumonia.
The overlap with RSV, influenza, and COVID-19 makes it nearly impossible to identify clinically without testing, and in practice, we often don’t test unless patients are hospitalized or part of an outbreak under investigation.
Why It Matters
Most patients recover with supportive care. But hMPV deserves attention for a few reasons: high-risk populations can become severely ill enough to need hospitalization. Unlike flu or COVID-19, there’s no vaccine and no specific antiviral, so care stays supportive: oxygen, fluids, symptom management. And hMPV adds to the seasonal burden on the system overall, and when it circulates alongside RSV and flu, pediatric and ICU beds can fill fast.
Current Reports
China had reported more cases the previous winter, mostly among children under 14 in northern provinces. The increase triggered heightened monitoring at the time, though local health authorities noted the pattern was typical for the season and not as severe as the same period the year before. The WHO emphasized that hMPV is a known virus, not a new or emerging threat, and said it did not represent a global health emergency.
What To Watch For
For physicians, it comes down to clinical awareness. If a patient has unexplained respiratory illness, especially if they’re very young, older, or immunocompromised, consider hMPV in the differential. For patients, the message is simple: good hygiene matters, and wash hands, avoid close contact when sick, and stay home if you’re symptomatic. These are the same steps that help reduce spread of other respiratory viruses.
hMPV doesn’t carry the same weight as influenza or COVID-19, but it plays a consistent role in seasonal respiratory disease, and understanding it helps us manage patients more effectively and prepare for the extra strain it can place on hospitals during peak months.
—
Scott Rennie, D.O.
Board Certified in Obesity Medicine and Family Medicine
This blog is for educational purposes only and does not constitute individual medical advice. Always consult your own physician before making changes to your health, medications, or treatment plan.
Sources
- Centers for Disease Control and Prevention. Human Metapneumovirus (hMPV). https://www.cdc.gov/human-metapneumovirus/about/index.html
- van den Hoogen BG, et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med. 2001;7(6):719-724. PMID 11385510.
- Panda S, Mohakud NK, Pena L, Kumar S. Human metapneumovirus: review of an important respiratory pathogen. Int J Infect Dis. 2014;25:45-52. PMID 24841931.
- World Health Organization. WHO statement on reported clusters of respiratory illness in children in northern China. 22 November 2023. https://www.who.int/news/item/22-11-2023-who-statement-on-reported-clusters-of-respiratory-illness-in-children-in-northern-china
